Bladder Cancer
Showing NaN - NaN of 51
Bladder Cancer Trial in Canada, United States (Bladder EpiCheck Urine Test, Cystoscopy and pathology)
Completed
- Bladder Cancer
- Bladder EpiCheck Urine Test
- Cystoscopy and pathology
-
Denver, Colorado
- +10 more
May 3, 2021
Bladder Cancer Trial in United States (CG0070)
Completed
- Bladder Cancer
- CG0070
-
Anchorage, Alaska
- +16 more
Apr 12, 2021
Transitional Cell Carcinoma, Bladder Cancer, Carcinoma in Situ Trial in United States (CG0070 Adenovirus Vector, Control Arm:
Terminated
- Transitional Cell Carcinoma
- +3 more
- CG0070 Adenovirus Vector
- Control Arm: Quadruple Choice
-
Phoenix, Arizona
- +6 more
Apr 12, 2021
Bladder Cancer Trial in Worldwide (Atezolizumab (MPDL3280A) [TECENTRIQ], an engineered anti-PDL1 antibody, Docetaxel,
Completed
- Bladder Cancer
- Atezolizumab (MPDL3280A) [TECENTRIQ], an engineered anti-PDL1 antibody
- +3 more
-
Washington, District of Columbia
- +216 more
Jul 5, 2019
Bladder Cancer Trial in Nashville (Immediate Surgery, Observation, Surveillance Cystoscopy and Urinary Cytology)
Terminated
- Bladder Cancer
- Immediate Surgery
- +2 more
-
Nashville, TennesseeVanderbilt University Medical Center
Aug 9, 2018
Bladder Cancer Trial in United States (Hexaminolevulinate HCl, KARL STORZ D-Light C PDD Flexible Videoscope System)
Completed
- Bladder Cancer
- Hexaminolevulinate hydrochloride
- KARL STORZ D-Light C PDD Flexible Videoscope System
-
Los Angeles, California
- +16 more
May 31, 2018
Anemia, NSCLC, Carcinoma, Small-Cell Lung Trial in United States (Sotatercept 15 mg, Sotatercept 30 mg)
Terminated
- Anemia
- +5 more
- Sotatercept 15 mg
- Sotatercept 30 mg
-
Phoenix, Arizona
- +40 more
Nov 14, 2017
Bladder Cancer Trial in Nashville (Ensure PlusĀ®, Multivitamin)
Completed
- Bladder Cancer
- Ensure PlusĀ®
- Multivitamin
-
Nashville, TennesseeVanderbilt University Medical Center
Mar 27, 2017
Bladder Cancer Trial in United States (filgrastim, cisplatin, doxorubicin HCl)
Completed
- Bladder Cancer
- filgrastim
- +3 more
-
Scottsdale, Arizona
- +284 more
Jul 12, 2016
Bladder Cancer, Cervical Cancer, Esophageal Cancer Trial in United States (nicotine lozenge, nicotine patch)
Completed
- Bladder Cancer
- +10 more
- nicotine lozenge
- nicotine patch
-
Washington, District of Columbia
- +9 more
Mar 1, 2016
Carcinoma in Situ, Bladder Cancer Trial in United States (Valrubicin, 800 mg)
Completed
- Carcinoma in Situ
- Bladder Cancer
- Valrubicin, 800 mg
-
Alabaster, Alabama
- +38 more
Jun 10, 2015
Local Tolerability of Intravesical Valrubicin in Non-muscle
Terminated
- Bladder Cancer
- CIS
-
Phoenix, Arizona
- +10 more
Jun 10, 2015
Bladder Cancer, Hemostasis Trial in Nashville (Stapling device during radical cystectomy, Ligasure tissue sealing device)
Terminated
- Bladder Cancer
- Hemostasis
- Stapling device during radical cystectomy
- Ligasure tissue sealing device
-
Nashville, TennesseeVanderbilt University Medical Center
Dec 21, 2013
Bladder Cancer Trial in Canada, United States (valrubicin, conventional surgery)
Unknown status
- Bladder Cancer
- valrubicin
- conventional surgery
-
Birmingham, Alabama
- +52 more
Nov 5, 2013
Bladder Cancer Trial in Worldwide (Hexvix, Standard white light cystoscopy)
Completed
- Bladder Cancer
- Hexvix
- Standard white light cystoscopy
-
Stanford, California
- +24 more
Aug 5, 2013
Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer Trial in United States (gemcitabine
Completed
- Bladder Cancer
- +2 more
- gemcitabine hydrochloride
- pemetrexed disodium
-
Aurora, Colorado
- +120 more
Nov 30, 2012
Transitional Cell Carcinoma, Bladder Tumors, Kidney Tumors Trial in Worldwide (vinflunine)
Completed
- Transitional Cell Carcinoma
- +5 more
-
Beverly Hills, California
- +74 more
Feb 27, 2010